1. Home
  2. IDXX

IDXX

IDEXX Laboratories Inc.

Logo IDEXX Laboratories Inc.

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Founded: N/A Country:
United States
United States
Employees: N/A City: WESTBROOK
Market Cap: 41.3B IPO Year: 1991
Target Price: $588.57 AVG Volume (30 days): 409.9K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 10.06 EPS Growth: 25.28
52 Week Low/High: $372.50 - $583.39 Next Earning Date: 05-01-2024
Revenue: $3,660,953,000 Revenue Growth: 8.72%
Revenue Growth (this year): 11.2% Revenue Growth (next year): 10.05%

Share on Social Networks: